{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:49:02Z","timestamp":1790812142135,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejphar.2013.10.018","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T21:49:09Z","timestamp":1382564949000},"page":"264-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Similar activity of mecamylamine stereoisomers in vitro and in vivo"],"prefix":"10.1016","volume":"720","author":[{"given":"Roger L.","family":"Papke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pretal","family":"Muldoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Imad Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.10.018_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib2","doi-asserted-by":"crossref","unstructured":"Chini, B., Clementi, F., Hukovic, N., Sher, E., 1992. Neuronal-type alpha-bungarotoxin receptors and the alpha 5- nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. Proc. Natl. Acad. Sci. USA 89, pp. 1572\u20131576.","DOI":"10.1073\/pnas.89.5.1572"},{"key":"10.1016\/j.ejphar.2013.10.018_bib3","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2013.10.018_bib4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)35238-3","article-title":"Pharmacological characterization of nicotine-induced seizures in mice","volume":"291","author":"Damaj","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib5","first-page":"1330","article-title":"Involvement of calcium and L-type channels in nicotine-induced antinociception","volume":"266","author":"Damaj","year":"1993","journal-title":"J. Pharmcol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02245100","article-title":"In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice","volume":"117","author":"Damaj","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2013.10.018_bib7","first-page":"74","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D\u2019Amour","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib8","first-page":"427","article-title":"Mecamylamine in the treatment of hypertension","volume":"46","author":"Dennis","year":"1957","journal-title":"J. Med. Assoc. Ga."},{"key":"10.1016\/j.ejphar.2013.10.018_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.108.146910","article-title":"Differential pharmacologies of mecamylamine enantiomers: positive allosteric modulation and noncompetitive inhibition","volume":"328","author":"Fedorov","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature09797","article-title":"Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake","volume":"471","author":"Fowler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.10.018_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuron.2011.04.013","article-title":"Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula","volume":"70","author":"Frahm","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2013.10.018_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib13","series-title":"Pharmacological properties of nicotinic agonists at the two stoichiometries of the alpha4beta2 and alpha2beta2 receptors, Nicotinic Acetylcholine Receptors","author":"Gurley","year":"2008"},{"key":"10.1016\/j.ejphar.2013.10.018_bib14","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1046\/j.1460-9568.2000.00262.x","article-title":"Localization of nAChR subunit mRNAs in the brain of Macaca mulatta","volume":"12","author":"Han","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.10.018_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/cne.10659","article-title":"Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta","volume":"461","author":"Han","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib16","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1523\/JNEUROSCI.1509-11.2011","article-title":"Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors","volume":"31","author":"Harpsoe","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.10.018_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.110.165738","article-title":"Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice","volume":"334","author":"Jackson","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2013.01.017","article-title":"The alpha3beta4\u204e nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the alpha5 subunit in the mouse","volume":"70","author":"Jackson","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.10.018_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/mol.110.066159","article-title":"Expression of functional human alpha6beta2beta3\u204e acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers","volume":"79","author":"Kuryatov","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/mol.108.046789","article-title":"Roles of accessory subunits in alpha4beta2(\u204e) nicotinic receptors","volume":"74","author":"Kuryatov","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/cn100070s","article-title":"(S)-(+)-Mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for major depressive disorder (MDD)","volume":"1","author":"Lindsley","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2013.10.018_bib22","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1021\/jm1003232","article-title":"Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation","volume":"53","author":"Lukas","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2013.10.018_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/19756","article-title":"Reduced antinociception in mice lacking neuronal nicotinic receptor subunits","volume":"398","author":"Marubio","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.10.018_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.10.018_bib25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0896-6273(89)90304-8","article-title":"Genetic manipulation of ion channels: a new approach to structure and mechanism","volume":"2","author":"Miller","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2013.10.018_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.108.149609","article-title":"Cytisine-based nicotinic partial agonists as novel antidepressant compounds","volume":"329","author":"Mineur","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12031-009-9261-0","article-title":"Tricks of Perspective: Insights and limitations to the study of macroscopic currents for the analysis of nAChR activation and desensitization","volume":"40","author":"Papke","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2013.10.018_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2006.04355.x","article-title":"The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery","volume":"101","author":"Papke","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.10.018_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuropharm.2008.03.010","article-title":"Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras","volume":"54","author":"Papke","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.10.018_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bcp.2012.04.022","article-title":"The nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their study","volume":"84","author":"Papke","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib31","article-title":"Nicotine Dependence and Depression, What is the Future for Therapeutics?","volume":"2","author":"Papke","year":"2012","journal-title":"J. Addict. Res. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib32","first-page":"646","article-title":"Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes","volume":"297","author":"Papke","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/jpet.109.164566","article-title":"Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes","volume":"333","author":"Papke","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.10.018_bib34","unstructured":"Papke, R.L., Zheng, G., Crooks, P.A., Dwoskin, L.P., 2006. Novel trivalent antagonists with selectivity for alpha_ nicotinic acetylcholine receptors, In: Proceedings of the 68th Annual Meeting College on Problems of Drug Dependence, Scottsdale, AZ."},{"key":"10.1016\/j.ejphar.2013.10.018_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-006-0568-z","article-title":"The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice","volume":"189","author":"Rabenstein","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2013.10.018_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1476-5381.2010.00682.x","article-title":"Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence","volume":"160","author":"Rollema","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1037\/1064-1297.6.3.331","article-title":"Nicotine-mecamylamine treatment for smoking cessation: the role of pre- cessation therapy","volume":"6","author":"Rose","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(05)60822-7","article-title":"Treatment of Tourette's syndrome with mecamylamine","volume":"352","author":"Sanberg","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2013.10.018_bib39","series-title":"Pharmacology of Nicotinic Acetylcholine Receptors from the Basic and Therapeutic Perspectives","first-page":"187","article-title":"Neuronal nicotinic receptors as therapeutic targets for mood disorders","author":"Shytle","year":"2011"},{"key":"10.1016\/j.ejphar.2013.10.018_bib40","unstructured":"Silver, A.A., Shytle, R.D., Sheehan, D.V., Sheehan, K.H., Ramos, A., Sanberg, P.R., 2000. Safety and exploratory study of mecamylamine monotherapy for Tourette's syndrome. In: Neuropharmacology: Proc. Neur.nAChR Symposium New Orleans, November 2\u20134."},{"key":"10.1016\/j.ejphar.2013.10.018_bib41","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00004583-200109000-00020","article-title":"Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder","volume":"40","author":"Silver","year":"2001","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.ejphar.2013.10.018_bib42","first-page":"205","article-title":"Mecamylamine (Targacept)","volume":"9","author":"Singh","year":"2006","journal-title":"IDrugs"},{"key":"10.1016\/j.ejphar.2013.10.018_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.neuropharm.2012.04.035","article-title":"Use of an alpha3-beta4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties","volume":"63","author":"Stokes","year":"2012","journal-title":"Neuropharm"},{"key":"10.1016\/j.ejphar.2013.10.018_bib44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/jm00107a019","article-title":"Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system","volume":"34","author":"Suchocki","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2013.10.018_bib45","series-title":"Manual of Pharmacological Calculations with Computer Programs","author":"Tallarida","year":"1987"},{"key":"10.1016\/j.ejphar.2013.10.018_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1476-5381.2012.01989.x","article-title":"Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of alpha2- and alpha4-containing nicotinic acetylcholine receptors","volume":"167","author":"Timmermann","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/cne.902840212","article-title":"Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat","volume":"284","author":"Wada","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib48","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/sj.bjp.0702686","article-title":"Antagonist activities of mecamylamine and nicotine show reciprocal dependence on beta subunit sequence in the second transmembrane domain","volume":"127","author":"Webster","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.10.018_bib49","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1523\/JNEUROSCI.23-27-09004.2003","article-title":"Human alpha4beta2 acetylcholine receptors formed from linked subunits","volume":"23","author":"Zhou","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.10.018_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2006.03.077","article-title":"5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors","volume":"539","author":"Zwart","year":"2006","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913007723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913007723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T18:09:09Z","timestamp":1746036549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913007723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0014299913007723"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.018","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Similar activity of mecamylamine stereoisomers in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}